Safety and effectiveness of the new P2Y12r inhibitor agents vs clopidogrel in ACS patients according to the geographic area: East Asia vs Europe

Giordana Francesca; Montefusco Antonio; DAscenzo Fabrizio; Moretti Claudio; Scarano Silvia; Abu-Assi Emad; Raposeiras-Roubin Sergio; Henriques Jose Paulo Simao; Saucedo Jorge; Ramon Gonzalez-Juanatey Jose; Wilton Stephen B.; Kikkert Wouter J.; Nunez-Gil Ivan; Ariza-Sole Albert; Song Xiantao; Alexopoulos Dimitrios; Liebetrau Christoph; Kawaji Tetsuma; Huczek Zenon; Nie Shao-Ping; Fujii Toshiharu; Correia Luis; Kawashiri Masa-aki; Maria Garcia-Acuna Jose; Southern Danielle; Alfonso Emilio; Terol Belen; Garay Alberto; Zhang Dongfeng; Chen Yalei; Xanthopoulou Ioanna; Osman Neriman; Moellmann Helge; Shiomi Hiroki; Kowara Michal; Filipiak Krzysztof; Wang Xiao; Yan Yan; Fan Jing-Yao; Ikari Yuji; Nakahayshi Takuya; Sakata Kenji; Yamagishi Masakazu; Kalpak Oliver; Kedev Sasko; Gaita F.

首页> 外文期刊>International Journal of Cardiology >Safety and effectiveness of the new P2Y12r inhibitor agents vs clopidogrel in ACS patients according to the geographic area: East Asia vs Europe

【24h】

Safety and effectiveness of the new P2Y12r inhibitor agents vs clopidogrel in ACS patients according to the geographic area: East Asia vs Europe

机译：新的P2Y12R抑制剂试剂对ACS患者的Clopidogrel的安全性和有效性，根据地理区域：东亚vs欧洲

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

摘要
著录项
相似文献
相关主题

摘要

Background: In the setting of the Acute Coronary Syndrome (ACS), differences in response to prasugrel and ticagrelor between East Asian and European patients have not been investigated yet.

机译：背景：在急性冠状动脉综合征（ACS）的设置中，尚未调查急性冠状动脉综合征（ACS）的差异，尚未调查东亚和欧洲患者之间的普拉布雷和TicagreloLoR。

著录项

来源
《International Journal of Cardiology》 |2016年第null期|共8页
作者
Giordana Francesca; Montefusco Antonio; DAscenzo Fabrizio; Moretti Claudio; Scarano Silvia; Abu-Assi Emad; Raposeiras-Roubin Sergio; Henriques Jose Paulo Simao; Saucedo Jorge; Ramon Gonzalez-Juanatey Jose; Wilton Stephen B.; Kikkert Wouter J.; Nunez-Gil Ivan; Ariza-Sole Albert; Song Xiantao; Alexopoulos Dimitrios; Liebetrau Christoph; Kawaji Tetsuma; Huczek Zenon; Nie Shao-Ping; Fujii Toshiharu; Correia Luis; Kawashiri Masa-aki; Maria Garcia-Acuna Jose; Southern Danielle; Alfonso Emilio; Terol Belen; Garay Alberto; Zhang Dongfeng; Chen Yalei; Xanthopoulou Ioanna; Osman Neriman; Moellmann Helge; Shiomi Hiroki; Kowara Michal; Filipiak Krzysztof; Wang Xiao; Yan Yan; Fan Jing-Yao; Ikari Yuji; Nakahayshi Takuya; Sakata Kenji; Yamagishi Masakazu; Kalpak Oliver; Kedev Sasko; Gaita F.;
展开▼
作者单位

Univ Turin Div Cardiol Citta Salute &

Sci Hosp I-10124 Turin Italy;

Univ Turin Div Cardiol Citta Salute &

Sci Hosp I-10124 Turin Italy;

Univ Turin Div Cardiol Citta Salute &

Sci Hosp I-10124 Turin Italy;

Univ Turin Div Cardiol Citta Salute &

Sci Hosp I-10124 Turin Italy;

Univ Turin Div Cardiol Citta Salute &

Sci Hosp I-10124 Turin Italy;

Univ Hosp Alvaro Cunqueiro Vigo Spain;

Univ Hosp Alvaro Cunqueiro Vigo Spain;

Univ Amsterdam Acad Med Ctr NL-1012 WX Amsterdam Netherlands;

NorthShore Univ Hosp Chicago IL USA;

Univ Clin Hosp Santiago De Compostela Santiago De Compostela Spain;

Libin Cardiovasc Inst Alberta Calgary AB Canada;

Univ Amsterdam Acad Med Ctr NL-1012 WX Amsterdam Netherlands;

San Carlos Hosp Madrid Spain;

Bellvitge Hosp Barcelona Spain;

Capital Med Univ Beijing Anzhen Hosp Beijing Peoples R China;

Univ Patras Hosp Athens Greece;

Kerckhoff Heart &

Thorax Ctr Frankfurt Germany;

Univ Clin Hosp Kyoto Japan;

Univ Clin Hosp Warsaw Poland;

Inst Heart Lung &

Blood Vessel Dis Beijing Peoples R China;

Tokai Univ Sch Med Tokyo Japan;

Hosp Sao Rafael Salvador BA Brazil;

Kanazawa Univ Grad Sch Med Div Cardiovasc Med Kanazawa Ishikawa Japan;

Univ Hosp Alvaro Cunqueiro Vigo Spain;

Libin Cardiovasc Inst Alberta Calgary AB Canada;

San Carlos Hosp Madrid Spain;

San Carlos Hosp Madrid Spain;

Bellvitge Hosp Barcelona Spain;

Capital Med Univ Beijing Anzhen Hosp Beijing Peoples R China;

Capital Med Univ Beijing Anzhen Hosp Beijing Peoples R China;

Univ Patras Hosp Athens Greece;

Kerckhoff Heart &

Thorax Ctr Frankfurt Germany;

Kerckhoff Heart &

Thorax Ctr Frankfurt Germany;

Univ Clin Hosp Kyoto Japan;

Univ Clin Hosp Warsaw Poland;

Univ Clin Hosp Warsaw Poland;

Inst Heart Lung &

Blood Vessel Dis Beijing Peoples R China;

Inst Heart Lung &

Blood Vessel Dis Beijing Peoples R China;

Inst Heart Lung &

Blood Vessel Dis Beijing Peoples R China;

Tokai Univ Sch Med Tokyo Japan;

Kanazawa Univ Grad Sch Med Div Cardiovasc Med Kanazawa Ishikawa Japan;

Kanazawa Univ Grad Sch Med Div Cardiovasc Med Kanazawa Ishikawa Japan;

Kanazawa Univ Grad Sch Med Div Cardiovasc Med Kanazawa Ishikawa Japan;

Univ Clin Cardiol Skopje Macedonia;

Univ Clin Cardiol Skopje Macedonia;

Univ Turin Div Cardiol Citta Salute &

Sci Hosp I-10124 Turin Italy;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类心脏、血管（循环系）疾病;
关键词
Acute coronary syndrome; Clopidogrel; Ethnicity; Platelet inhibitor; Prasugrel; P2Y12 receptor; Ticagrelor;

机译：急性冠心综合征;氯吡格雷;种族;血小板抑制剂;普拉布雷;P2Y12受体;Ticagrelor;

相似文献

外文文献
中文文献
专利

1. Safety and effectiveness of the new P2Y12r inhibitor agents vs clopidogrel in ACS patients according to the geographic area: East Asia vs Europe [J] . Giordana Francesca, Montefusco Antonio, DAscenzo Fabrizio, International Journal of Cardiology . 2016,第Null期

机译：新的P2Y12R抑制剂试剂对ACS患者的Clopidogrel的安全性和有效性，根据地理区域：东亚vs欧洲
2. Safety and effectiveness of the new P2Y12r inhibitor agents vs clopidogrel in ACS patients according to the geographic area: East Asia vs Europe [J] . Giordana Francesca, Montefusco Antonio, DAscenzo Fabrizio, International Journal of Cardiology . 2016,第Null期

机译：根据地理区域，新的P2Y12r抑制剂与氯吡格雷对ACS患者的安全性和有效性：东亚与欧洲
3. Safety and effectiveness of the new P2Y12r inhibitor agents vs clopidogrel in ACS patients according to the geographic area: East Asia vs Europe [J] . Giordana Francesca, Montefusco Antonio, DAscenzo Fabrizio, International Journal of Cardiology . 2016,第Null期

机译：根据地理区域，新的P2Y12r抑制剂与氯吡格雷对ACS患者的安全性和有效性：东亚与欧洲
4. POSSIBLE ROLE OF THE NETWORK OF AQUACULTURE CENTRES IN CENTRAL AND EASTERN EUROPE (NACEE) IN AQUACULTURE DEVELOPMENT OF THE DEVELOPING ASIAN COUNTRIES [C] . Peter Lengyel, Laszlo Varadi Annual Meeting of the European Aquaculture Society . 2013

机译：水产养殖中心的可能作用在中欧和东欧（Nacee）在发展中亚洲国家的水产养殖发展中
5. The Comparative Effectiveness, Safety, Value, and Adherence of Newer P2Y12 Inhibitors versus Clopidogrel in the Context of Heterogeneity [D] . Suh, Kangho. 2019

机译：新的P2Y12抑制剂与氯吡格雷在异质性的比较有效性，安全性，价值和依从性
6. Impact of Proton Pump Inhibitor Use on the Comparative Effectiveness and Safety of Prasugrel Versus Clopidogrel: Insights From the Treatment With Adenosine Diphosphate Receptor Inhibitors: Longitudinal Assessment of Treatment Patterns and Events After Acute Coronary Syndrome (TRANSLATE‐ACS) Study [O] . Larry R. Jackson II, Eric D. Peterson, Lisa A. McCoy, 2016

机译：质子泵抑制剂的使用对普拉格雷与氯吡格雷的比较有效性和安全性的影响：用二磷酸腺苷受体抑制剂治疗的见解：纵向评估急性冠脉综合征后的治疗方式和事件（TRANSLATE‐ACS）
7. PCV24 - SAFETY AND EFFECTIVENESS OF CONTEMPORARY P2Y12 INHIBITORS IN EAST ASIAN PATIENTS WITH ACUTE CORONARY SYNDROMES: A NATIONWIDE POPULATION-BASED COHORT STUDY [O] . J.E. Yun 2018

机译：PCV24 - 当代P2Y12急性冠状动脉综合征患者当代P2Y12抑制剂的安全性和有效性：全国范围的人口队列队列研究

Safety and effectiveness of the new P2Y12r inhibitor agents vs clopidogrel in ACS patients according to the geographic area: East Asia vs Europe

摘要

著录项

相似文献

相关主题

期刊订阅